Mirum Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2022
Total Assets: $352.9M
Liabilities Breakdown FY2022
Total Liabilities: $210.9M
Asset Breakdown
Total Assets: $352.9M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $28.0M | 7.9% |
| Accounts Receivable | $24.0M | 6.8% |
| Inventory | $5.6M | 1.6% |
| Property, Plant & Equipment | $914.0K | 0.3% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $59.0M | 16.7% |
| Other Assets | $235.5M | 66.7% |
Liabilities Breakdown
Total Liabilities: $210.9M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $8.7M | 4.1% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $202.2M | 95.9% |